Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ejcts/ezaa332 http://scihub22266oqcxt.onion/10.1093/ejcts/ezaa332 33150417!7665486!33150417     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33150417&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Eur+J+Cardiothorac+Surg 2020 ; 58 (6): 1222-1227 Nephropedia Template TP {{tp|p=33150417|t=2020. Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic |pdf=|usr=}}{{33150417}} gab.com Text Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic JO: Eur J Cardiothorac Surg http://www.kidney.de/pget.php?&tw=1&pmid=33150417 #FOAvip OBJECTIVES: The coronavirus disease 2019 (COVID-19) pandemic has resulted in patient reluctance to seek care due to fear of contracting the virus, especially in New York City which was the epicentre during the surge. The primary objectives of this study are to evaluate the safety of patients who have undergone pulmonary resection for lung cancer as well as provider safety, using COVID-19 testing, symptoms and early patient outcomes. METHODS: Patients with confirmed or suspected pulmonary malignancy who underwent resection from 13 March to 4 May 2020 were retrospectively reviewed. RESULTS: Between 13 March and 4 May 2020, 2087 COVID-19 patients were admitted, with a median daily census of 299, to one of our Manhattan campuses (80% of hospital capacity). During this time, 21 patients (median age 72 years) out of 45 eligible surgical candidates underwent pulmonary resection-13 lobectomies, 6 segmentectomies and 2 pneumonectomies were performed by the same providers who were caring for COVID-19 patients. None of the patients developed major complications, 5 had minor complications, and the median length of hospital stay was 2 days. No previously COVID-19-negative patient (n = 20/21) or healthcare provider (n = 9: 3 surgeons, 3 surgical assistants, 3 anaesthesiologists) developed symptoms of or tested positive for COVID-19. CONCLUSIONS: Pulmonary resection for lung cancer is safe in selected patients, even when performed by providers who care for COVID-19 patients in a hospital with a large COVID-19 census. None of our patients or providers developed symptoms of COVID-19 and no patient experienced major morbidity or mortality. Twit Text FOAVip Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic ????Eur J Cardiothorac Surg http://www.kidney.de/pget.php?&tw=1&pmid=33150417 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33150417 #FOAvip English Wikipedia <ref>{{Cite pmid|33150417}}</ref> Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic #MMPMID33150417 Chang SH; Zervos M; Kent A; Chachoua A; Bizekis C; Pass H; Cerfolio RJ Eur J Cardiothorac Surg 2020[Dec]; 58 (6): 1222-1227 PMID33150417show ga OBJECTIVES: The coronavirus disease 2019 (COVID-19) pandemic has resulted in patient reluctance to seek care due to fear of contracting the virus, especially in New York City which was the epicentre during the surge. The primary objectives of this study are to evaluate the safety of patients who have undergone pulmonary resection for lung cancer as well as provider safety, using COVID-19 testing, symptoms and early patient outcomes. METHODS: Patients with confirmed or suspected pulmonary malignancy who underwent resection from 13 March to 4 May 2020 were retrospectively reviewed. RESULTS: Between 13 March and 4 May 2020, 2087 COVID-19 patients were admitted, with a median daily census of 299, to one of our Manhattan campuses (80% of hospital capacity). During this time, 21 patients (median age 72 years) out of 45 eligible surgical candidates underwent pulmonary resection-13 lobectomies, 6 segmentectomies and 2 pneumonectomies were performed by the same providers who were caring for COVID-19 patients. None of the patients developed major complications, 5 had minor complications, and the median length of hospital stay was 2 days. No previously COVID-19-negative patient (n = 20/21) or healthcare provider (n = 9: 3 surgeons, 3 surgical assistants, 3 anaesthesiologists) developed symptoms of or tested positive for COVID-19. CONCLUSIONS: Pulmonary resection for lung cancer is safe in selected patients, even when performed by providers who care for COVID-19 patients in a hospital with a large COVID-19 census. None of our patients or providers developed symptoms of COVID-19 and no patient experienced major morbidity or mortality. |*Pneumonectomy[MESH] |Adenocarcinoma/surgery[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19 Testing[MESH] |COVID-19/diagnosis/epidemiology/*prevention & control/transmission[MESH] |Carcinoma, Non-Small-Cell Lung/*surgery[MESH] |Cross Infection/diagnosis/epidemiology/prevention & control[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Health Services Accessibility[MESH] |Hospitalization[MESH] |Humans[MESH] |Infection Control/*methods[MESH] |Infectious Disease Transmission, Patient-to-Professional/*prevention & control/statistics & numerical data[MESH] |Lung Neoplasms/*surgery[MESH] |Male[MESH] |Middle Aged[MESH] |New York City/epidemiology[MESH] |Pandemics[MESH] |Patient Safety/statistics & numerical data[MESH] |Patient Selection[MESH] |Perioperative Care/methods[MESH] |Postoperative Complications/diagnosis/epidemiology/*prevention & control[MESH] |Retrospective Studies[MESH]Safety of patients and providers in lung cancer surgery during the COV(epmc).pdf DeepDyve Pubget Overpricing